97 related articles for article (PubMed ID: 2600939)
1. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis.
Berntzen HB; Munthe E; Fagerhol MK
J Rheumatol; 1989 Nov; 16(11):1416-20. PubMed ID: 2600939
[TBL] [Abstract][Full Text] [Related]
2. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity.
Brun JG; Haga HJ; Bøe E; Kallay I; Lekven C; Berntzen HB; Fagerhol MK
J Rheumatol; 1992 Jun; 19(6):859-62. PubMed ID: 1404121
[TBL] [Abstract][Full Text] [Related]
3. The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis.
Berntzen HB; Fagerhol MK; Ostensen M; Mowinckel P; Høyeraal HM
J Rheumatol; 1991 Jan; 18(1):133-8. PubMed ID: 2023183
[TBL] [Abstract][Full Text] [Related]
4. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
Wolfe F
J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
[TBL] [Abstract][Full Text] [Related]
5. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases.
Brun JG; Jonsson R; Haga HJ
J Rheumatol; 1994 Apr; 21(4):733-8. PubMed ID: 8035402
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
7. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.
Ertenli I; Kiraz S; Arici M; Haznedaroglu IC; Calgüneri M; Celik I; Kirazli S
J Rheumatol; 1998 Jun; 25(6):1054-8. PubMed ID: 9632062
[TBL] [Abstract][Full Text] [Related]
8. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
Ellingsen T; Buus A; Stengaard-Pedersen K
J Rheumatol; 2001 Jan; 28(1):41-6. PubMed ID: 11196541
[TBL] [Abstract][Full Text] [Related]
9. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.
Yildirim K; Karatay S; Melikoglu MA; Gureser G; Ugur M; Senel K
Ann Clin Lab Sci; 2004; 34(4):423-6. PubMed ID: 15648784
[TBL] [Abstract][Full Text] [Related]
10. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.
Dessein PH; Joffe BI; Stanwix AE
J Rheumatol; 2004 Jun; 31(6):1095-7. PubMed ID: 15170920
[TBL] [Abstract][Full Text] [Related]
11. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
13. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
Mallya RK; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
J Rheumatol; 1982; 9(2):224-8. PubMed ID: 7097681
[TBL] [Abstract][Full Text] [Related]
14. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
Sokka T; Pincus T
J Rheumatol; 2009 Jul; 36(7):1387-90. PubMed ID: 19411389
[TBL] [Abstract][Full Text] [Related]
16. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
17. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
Berntzen HB; Olmez U; Fagerhol MK; Munthe E
Scand J Rheumatol; 1991; 20(2):74-82. PubMed ID: 1709519
[TBL] [Abstract][Full Text] [Related]
18. Levels of antioxidant proteins and soluble intercellular adhesion molecule-1 in serum of patients with rheumatoid arthritis.
Cogalgil S; Taysi S
Ann Clin Lab Sci; 2002; 32(3):264-70. PubMed ID: 12175089
[TBL] [Abstract][Full Text] [Related]
19. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
[TBL] [Abstract][Full Text] [Related]
20. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate.
Yazici Y; Pincus T; Kautiainen H; Sokka T
J Rheumatol; 2004 Sep; 31(9):1723-6. PubMed ID: 15338490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
